Kevin Cannon, MD
Hospitalist · Wilmington, NCNPI 1700897022
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,007 of the $4,896 with a category attached, or 61.4%. 8 manufacturers reported payments, led by Novo Nordisk AS at 42.3% of the total. Reporting peaked in 2019 at $3,301 and has fallen 96.5% since, to $116 in 2025. Among hospitalist clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 35 payments — averaging $139.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$2K
- Boehringer Ingelheim International GmbH$1K
- Pfizer$1K
- Corcept Therapeutics$149
- Novartis$91
- Novo Nordisk$65
- plus $57 from 2 others
Across 7,131 payments — averaging $6669.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$16.8M
- Regeneron$11.9M
- Novo Nordisk AS$3.7M
- Modernatx, Inc.$2.6M
- Bavarian Nordic A/s$2.5M
- Johnson & Johnson$1.9M
- plus $8.1M from 20 others
What the payments were for
- Travel & lodging$3,00761%
- Food & beverage$1,80437%
- Education$651%
- Gifts$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 10 | $2,071 |
| Boehringer Ingelheim International GmbH | 12 | $1,244 |
| Pfizer | 6 | $1,219 |
| Corcept Therapeutics | 2 | $149 |
| Novartis | 1 | $91 |
| Novo Nordisk | 2 | $65 |
| Philips North America LLC | 1 | $32 |
| Boehringer Ingelheim | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PREVNAR - 13$1,169
- Saxenda$808
- Korlym$124
How this compares
$4,896 in reported general payments places this provider in the 90th percentile of 879 hospitalist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Furosemide | 14 | $19 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Wilmington
- Mahesh ChandrasekharWinston Salem$86K
- Dwan VarnerGreenville$59K
- Honnie SpencerSalisbury$50K
- Ria DancelChapel Hill$13K
- Javad MonzavifarCharlotte$12K
- Bikki GautamCharlotte$12K
- Jorge PaulinoCharlotte$12K
- Emmett StewardCharlotte$11K
- Stephan HewittGastonia$11K
- Juan Velasco-TrujilloMatthews$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.